Abstract: A negative electrode for a lithium secondary battery that includes, as a negative active material, a lithium titanate (Li4Ti5O12) compound containing 0.004 parts by weight or less of phosphorous (P) and 0.007 parts by weight or less of potassium (K) based on 100 parts by weight of lithium titanate, a binder, and a conductive agent, and a lithium secondary battery including the negative electrode.

Abstract: The present invention relates herein to compounds and compositions for the treatment and amelioration of inflammatory disease. Specifically the present invention relates to compounds that having a tryptase inhibition activity and the intermediates thereof, pharmaceutical compositions comprising such compounds, and a method of treating subjects suffering from a condition disease or disorder that can be ameliorated by the administration of an inhibitor of tryptase.

Abstract: The present invention relates to substituted 2-amino-N-(4-fluoro-3-{1-[1-(alkyl)-1H-indole-3-carbonyl]-piperidin-4-yl}-benzyl)-acetamides (compounds of formula I) compositions thereof, and their use in the treatment of inflammatory diseases.

Abstract: The present invention discloses and claims a series of substituted tropinone benzylamines of formula (I): The compounds of this invention are inhibitors of ?-tryptase and are, therefore, useful as pharmaceutical agents. Additionally, this invention also discloses methods of preparation of substituted tropinone benzylamines.

Abstract: The present invention relates to a method for the treatment of an inflammatory bowel disease by the administration of the compound [4-(5-aminomethyl-2-fluorophenyl)piperidine-1-yl][7-fluoro-1-(2-methoxyethyl)-4-trifluoromethoxy-1H-indol-3-yl]methanone, which may be represented as Formula I: or a corresponding N-oxide, prodrug, pharmaceutically acceptable salt or solvate thereof.

Abstract: A circuit, including a first impedance unit having an impedance value based on a first impedance code and configured to drive a first node coupled with a resistor with a first voltage, a first code generation unit configured to generate the first impedance code so that an impedance value of the first impedance unit and an impedance value of the resistor are at a ratio of X:Y, dummy impedance units that receive the first impedance code and drive a second node with the first voltage, a second impedance unit having an impedance value based on a second impedance code and configured to drive the second node with a second voltage, and a second code generation unit configured to generate the second impedance code so that an overall impedance value of the dummy impedance units and an impedance value of the second impedance unit are at a ratio of X:Y

Abstract: The present invention relates to a series of substituted 3-aminopropane phosphinic acid derivatives of formula I: wherein R, R1, P1, P2 and P3 are as defined herein. The compounds of this invention are useful in treating a variety of diseases including but not limited to depression, anxiety, certain psychiatric symptoms, cognitive impairment and schizophrenia.

Abstract: A method of testing a semiconductor memory apparatus is provided. The data alignment units other than the one data align unit being tested are deactivated. Serial data is input to the activated data alignment unit to generate parallel data. The parallel data is decoded. A test mode signal corresponding to the decoded result is enabled to perform the test. Different serial data is input where the test mode signal is enabled to generate and decode parallel data. Both tests are then performed simultaneously based on a test mode signal corresponding to a result of the decoded parallel data.

Abstract: The present invention is directed to an indole benzylamine compound of formula I: useful as an inhibitor of tryptase. In addition, the present invention is directed to the use of the compound for treating a patient suffering from, or subject to, a physiological condition in need of amelioration by inhibition of tryptase, comprising administering to the patient of a therapeutically effective amount of the compound, and to a pharmaceutical composition comprising a pharmaceutically effective amount of the compound of formula I, and a pharmaceutically acceptable carrier.

Abstract: The present invention extends to a compound of formula I: or a pharmaceutically acceptable salt of said compound, or a pharmaceutical composition comprising the compound of formula I and a pharmaceutically acceptable carrier. The invention is also directed to the use of a compound of formula I as an inhibitor of tryptase and for treating a patient suffering from, or subject to, a physiological condition in need of amelioration by an inhibitor of tryptase. The invention further includes methods for the preparation of a compound of formula I.

Abstract: The present invention relates to a series of substituted 3-aminopropane phosphinic acid derivatives of formula I: wherein R, R1, P1, P2 and P3 are as defined herein. The compounds of this invention are useful in treating a variety of diseases including but not limited to depression, anxiety, certain psychiatric symptoms, cognitive impairment and schizophrenia.

Abstract: A memory device for storing a plurality of macroblocks may include a plurality of memory banks. Each macroblock may include m*n pixel data, wherein m is a positive integer, and wherein n also is a positive integer. The plurality of memory banks is adapted to store the pixel data, and wherein each memory bank is sized to store rows of m pixel data. An image processing system may include: a memory adapted to store a plurality of macroblocks; and a video codec. The memory may include a plurality of memory banks. Each memory bank may be sized to store rows of m pixel data. The video codec may be adapted to encode pixel data read from the memory. The video codec also may be adapted to decode the pixel data read from the memory.

Abstract: A semiconductor apparatus includes a comparison voltage generation unit configured to generate a plurality of different comparison voltages, a reference voltage generation unit configured to receive a generation code from an external system, select one of the plurality of the different comparison voltages according to the generation code, and generate a reference voltage, and a reference voltage determination unit configured to receive the generation code and an expected reference voltage from the external system, check whether a level of the expected reference voltage is in a target range, and output a check result to the external system.

Abstract: A semiconductor memory apparatus according to the embodiment includes a test mode controller, a first data alignment unit, a decoder, a test executing unit and a second data alignment unit. The test mode controller is configured to generate test enable signals in response to a test mode setting signal and a read command. The first data alignment unit is configured to parallely align first input data that are input in series, generate first alignment data, and transmit it to the first data driver. The decoder is configured to decode the first alignment data in response to the test enable signal and generate the decoding signal. The test executing unit is configured to execute the preset test mode in response to the decoding signal. The second data alignment unit is configured to parallely align second input data, which are input in series, in response to the test enable signal, generate second alignment data, and transmit it to a second data driver.

Abstract: A data output circuit of a semiconductor memory apparatus includes: a data control driver configured to drive rising data and falling data to output control rising data and control falling data or drive level data to output the control rising data and the control falling data, in response to an output level test signal; a DLL clock control unit configured to drive a rising clock and a falling clock to output a control rising clock and a control falling clock in response to an enable signal and the output level test signal; and a clock synchronization unit configured to synchronize the control rising data and the control falling data with the control rising clock and the control falling clock to output serial rising data and serial falling data.

Abstract: A negative active material containing super-conductive nanoparticles coated with a high capacity negative material and a lithium battery including the same are provided, wherein the super-conductive nanoparticles have a structure in which polycyclic nano-sheets are stacked upon one another along a direction perpendicular to a first plane. The polycyclic nano-sheets include hexagonal rings of six carbons atoms linked to each other, wherein a first carbon and a second carbon have a distance therebetween of L1. L2 is a distance between a third carbon and a fourth carbon, and the arrangement of the polycyclic nano-sheets is such that L1?L2. The super-conductive nanoparticle is used as a negative active material in a lithium battery, and the super-conductive nanoparticle increases the capacity, thereby improving the capacity and lifespan of the lithium battery.

Abstract: A lithium titanate aggregate and a method of preparing the same. In the lithium titanate aggregate, a single primary particle has a median diameter (D50) of about 8×10?2 ?m to about 3.1×10?1 ?m, and has a spherical shape. In addition, an amount of primary particles having a diameter of about 55 nm to about 85 nm is about 55% to about 75% of all primary particles.

Abstract: A data strobe signal generating circuit includes a pre-driver control unit for selectively transferring a ground voltage and a supply voltage, as a first control signal and a second control signal, in response to first and second clock pulse signals, wherein the second control signal is driven in response to a preamble signal, a pre-driver for generating a driving signal in response to the first and second control signals and the preamble signal, and an output buffer for driving an output pad in response to the driving signal.

Abstract: A voltage stabilization circuit of a semiconductor memory apparatus includes an operation speed detecting unit configured to detect an operation speed of the semiconductor memory apparatus to generate a detection signal, and a voltage line controlling unit configured to interconnect a first voltage line and a second voltage line in response to the detection signal.

Abstract: The present invention is directed to an indole benzylamine compound of formula I: useful as an inhibitor of tryptase. In addition, the present invention is directed to the use of the compound for treating a patient suffering from, or subject to, a physiological condition in need of amelioration by inhibition of tryptase, comprising administering to the patient of a therapeutically effective amount of the compound, and to a pharmaceutical composition comprising a pharmaceutically effective amount of the compound of formula I, and a pharmaceutically acceptable carrier.